FluoGuide is trading at SEK 31.90 (down 5.1%) as the stock continues to track a broader de-risking trend across growth and high-beta biotech names.
- The recent price action follows several sessions of volatile declines within the sector, with moves attributed to general market sentiment rather than company-specific developments.
- No fresh corporate announcements or earnings releases have emerged to explain the latest drop, suggesting that sector-wide risk-off pressure remains the primary driver.